- Home
- XWIN vs TLPH Comparison
XWIN vs TLPH Comparison
Compare XWIN & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XWIN
- TLPH
- Stock Information
- Founded
- XWIN 2003
- TLPH 2005
- Country
- XWIN United States
- TLPH United States
- Employees
- XWIN N/A
- TLPH N/A
- Industry
- XWIN Home Furnishings
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- XWIN Consumer Discretionary
- TLPH Health Care
- Exchange
- XWIN Nasdaq
- TLPH Nasdaq
- Market Cap
- XWIN 75.2M
- TLPH 64.7M
- IPO Year
- XWIN N/A
- TLPH 2011
- Fundamental
- Price
- XWIN $5.74
- TLPH $1.34
- Analyst Decision
- XWIN
- TLPH Strong Buy
- Analyst Count
- XWIN 0
- TLPH 1
- Target Price
- XWIN N/A
- TLPH $6.00
- AVG Volume (30 Days)
- XWIN 911.6K
- TLPH 318.3K
- Earning Date
- XWIN 11-13-2025
- TLPH 11-12-2025
- Dividend Yield
- XWIN N/A
- TLPH N/A
- EPS Growth
- XWIN N/A
- TLPH N/A
- EPS
- XWIN N/A
- TLPH N/A
- Revenue
- XWIN $16,959,274.00
- TLPH $28,000.00
- Revenue This Year
- XWIN N/A
- TLPH N/A
- Revenue Next Year
- XWIN N/A
- TLPH $14,533.26
- P/E Ratio
- XWIN N/A
- TLPH N/A
- Revenue Growth
- XWIN 70.36
- TLPH N/A
- 52 Week Low
- XWIN $0.39
- TLPH $0.38
- 52 Week High
- XWIN $6.08
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- XWIN N/A
- TLPH 57.82
- Support Level
- XWIN N/A
- TLPH $1.01
- Resistance Level
- XWIN N/A
- TLPH $1.35
- Average True Range (ATR)
- XWIN 0.00
- TLPH 0.11
- MACD
- XWIN 0.00
- TLPH -0.01
- Stochastic Oscillator
- XWIN 0.00
- TLPH 80.49
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.